Machine Learning Helps Predict Lymphoma Immunotherapy Response

[Machine Learning Empowers Lymphoma Immunotherapy Prediction]

A newly developed tool utilizes machine learning to help predict the effectiveness of CAR T-cell therapy in lymphoma patients by measuring blood inflammation markers. This brings new hope for more personalized and effective treatments.

Key Data:

• Patients using this new test saw a 60% improvement in prediction accuracy.
• Blood inflammation markers identified up to 70% of patients who would have a poor treatment response.
• This tool helps medical teams adjust treatment plans more effectively, improving patient quality of life.

For more details, please visit: https://tinyurl.com/2a6x4s69

Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).

Figure 1

Figure 2

Figure 3

Figure 4